Clinical Trial: STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603700) titled 'STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism' on March 24.

Brief Summary: This study aims to compare the effectiveness and safety of three treatment strategies (Anticoagulation, Thrombolysis, and Mechanical Thrombectomy) for patients with intermediate-high risk acute pulmonary embolism (PE) in a real-world setting. Approximately 1,300 patients will be enrolled across multiple centers in China. Patients will be followed for 90 days to assess mortality, heart function recovery, bleeding risks, and quality of life. The results will help guide personalized treatment decisions and healthcare p...